CORT
Corcept Therapeutics Incorporated
Stock
$116.23+2.20 (+1.93%)Close Oct 2, 2026
- Capital expenditures, 2025
- $211K
- YoY, 2025
- −90.3%
- 5-year CAGR
- −29.8%
- 10-year CAGR
- +28.6%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $211K | −90.3% |
| 2024 | $2.2M | +1,462.6% |
| 2023 | $139K | −66.3% |
| 2022 | $413K | −11.9% |
| 2021 | $469K | −62.1% |
| 2020 | $1.2M | +13.8% |
| 2019 | $1.1M | +265.1% |
| 2018 | $298K | −28.9% |
| 2017 | $419K | +116.0% |
| 2016 | $194K | +1,041.2% |
| 2015 | $17K | −90.2% |
| 2014 | $174K | +37.0% |
| 2013 | $127K | −15.9% |
| 2012 | $151K | +504.0% |
| 2011 | $25K | — |